{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:30:57Z","timestamp":1793410257838,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.meddos.2026.08.001","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:13:26Z","timestamp":1789244006000},"page":"512-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re-evaluating the \u03b1\/\u03b2 ratio in 2026: A systematic review and quantitative reappraisal in the era of molecular radiobiology"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6539-5432","authenticated-orcid":false,"given":"Noureddine","family":"Samai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymen","family":"Berremdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meddos.2026.08.001_bib0001","series-title":"Basic clinical radiobiology","author":"Joiner","year":"2009"},{"issue":"2","key":"10.1016\/j.meddos.2026.08.001_bib0002","first-page":"140","article-title":"BeSyond the linear quadratic model: Intraoperative radiotherapy and normal tissue tolerance","volume":"4","author":"Emami","year":"2015","journal-title":"Transl. Cancer Res"},{"issue":"7","key":"10.1016\/j.meddos.2026.08.001_bib0003","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/0284186X.2018.1433874","article-title":"Clinical estimation of \u03b1\/\u03b2 values for prostate cancer from isoeffective phase III randomized trials with moderately hypofractionated radiotherapy","volume":"57","author":"Datta","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.meddos.2026.08.001_bib0004","article-title":"Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer","volume":"39","author":"Tran","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol"},{"issue":"2","key":"10.1016\/j.meddos.2026.08.001_bib0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): A retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.meddos.2026.08.001_bib0006","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(21)00347-8","article-title":"Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): A cohort-based pooled analysis","volume":"22","author":"Scott","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.meddos.2026.08.001_bib0007","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.meddos.2026.08.001_bib0008","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"A phase III randomized controlled trial of Stereotactic Body Radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"N. Engl. J. Med"},{"issue":"14","key":"10.1016\/j.meddos.2026.08.001_bib0009","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.3390\/cancers15143659","article-title":"Radiobiological meta-analysis of the response of prostate cancer to different fractionations: Evaluation of the linear-quadratic response at large doses and the effect of risk and ADT","volume":"15","author":"Pardo-Montero","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.meddos.2026.08.001_bib0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1470-2045(20)30607-0","article-title":"Hypofractionated radiotherapy in locally advanced bladder cancer: An individual patient data meta-analysis of the BC2001 and BCON trials","volume":"22","author":"Choudhury","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.meddos.2026.08.001_bib0011","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(23)00513-2","article-title":"Stereotactic body radiotherapy for primary renal cell carcinoma: A systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)","volume":"25","author":"Siva","year":"2024","journal-title":"Lancet Oncol"},{"issue":"28","key":"10.1016\/j.meddos.2026.08.001_bib0012","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-year results of FAST: A randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt","year":"2020","journal-title":"J. Clin. Oncol"},{"issue":"7","key":"10.1016\/j.meddos.2026.08.001_bib0013","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clon.2021.04.016","article-title":"Five-fraction radiotherapy for breast cancer: FAST-forward to implementation","volume":"33","author":"Brunt","year":"2021","journal-title":"Clin. Oncol. (R Coll. Radiol.)"},{"issue":"2","key":"10.1016\/j.meddos.2026.08.001_bib0014","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2016.11.006","article-title":"Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models","volume":"122","author":"Liu","year":"2017","journal-title":"Radiother. Oncol"},{"key":"10.1016\/j.meddos.2026.08.001_bib0015","first-page":"147","article-title":"Estimation of the \u03b1\/\u03b2 ratio of non-small cell lung cancer treated with stereotactic body radiotherapy","volume":"139","author":"Klement","year":"2019","journal-title":"Radiother. Oncol"},{"issue":"1","key":"10.1016\/j.meddos.2026.08.001_bib0016","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"issue":"6","key":"10.1016\/j.meddos.2026.08.001_bib0017","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5603\/NJO.a2022.0056","article-title":"Short-course radiotherapy as part of total neoadjuvant therapy for locally advanced rectal cancer - a new standard?","volume":"72","author":"Suwi\u0144ski","year":"2022","journal-title":"NOWOTWORY J. Oncol"},{"issue":"4","key":"10.1016\/j.meddos.2026.08.001_bib0018","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.1097\/SLA.0000000000005799","article-title":"Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: A 5-year follow-up of the RAPIDO trial","volume":"278","author":"Dijkstra","year":"2023","journal-title":"Ann. Surg"},{"issue":"13","key":"10.1016\/j.meddos.2026.08.001_bib0019","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J. Clin. Oncol"},{"issue":"1","key":"10.1016\/j.meddos.2026.08.001_bib0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2024.03.013","article-title":"Radiation therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas","volume":"120","author":"Tchelebi","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"10.1016\/j.meddos.2026.08.001_bib0021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13014-023-02278-5","article-title":"Improving the efficacy of combined radiotherapy and immunotherapy: Focusing on the effects of radiosensitivity","volume":"18","author":"Gao","year":"2023","journal-title":"Radiat. Oncol"}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394726000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394726000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:50:08Z","timestamp":1793407808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394726000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"alternative-id":["S0958394726000592"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2026.08.001","relation":{},"ISSN":["0958-3947"],"issn-type":[{"value":"0958-3947","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-evaluating the \u03b1\/\u03b2 ratio in 2026: A systematic review and quantitative reappraisal in the era of molecular radiobiology","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2026.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}